Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$63.47 - $69.35 $287,582 - $314,224
-4,531 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$60.0 - $68.46 $227,340 - $259,394
3,789 Added 510.65%
4,531 $293,000
Q4 2020

Feb 11, 2021

SELL
$56.65 - $64.55 $339 - $387
-6 Reduced 0.8%
742 $43,000
Q3 2020

Nov 09, 2020

SELL
$62.1 - $78.08 $653,975 - $822,260
-10,531 Reduced 93.37%
748 $47,000
Q2 2020

Aug 12, 2020

SELL
$72.34 - $84.0 $6,076 - $7,056
-84 Reduced 0.74%
11,279 $868,000
Q1 2020

May 12, 2020

BUY
$62.63 - $80.22 $143,360 - $183,623
2,289 Added 25.23%
11,363 $849,000
Q4 2019

Feb 10, 2020

SELL
$61.62 - $67.78 $310,749 - $341,814
-5,043 Reduced 35.72%
9,074 $590,000
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $407,065 - $449,328
6,512 Added 85.63%
14,117 $895,000
Q2 2019

Aug 08, 2019

SELL
$61.87 - $69.38 $520,883 - $584,110
-8,419 Reduced 52.54%
7,605 $514,000
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $778,248 - $871,842
12,446 Added 347.85%
16,024 $1.04 Million
Q4 2018

Feb 06, 2019

BUY
$60.54 - $79.0 $1,271 - $1,659
21 Added 0.59%
3,578 $224,000
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $2,423 - $2,683
34 Added 0.97%
3,557 $275,000
Q2 2018

Aug 09, 2018

BUY
$64.88 - $75.68 $199,376 - $232,564
3,073 Added 682.89%
3,523 $250,000
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $393,773 - $480,052
-5,406 Reduced 92.32%
450 $0
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $480,760 - $564,344
-6,757 Reduced 53.57%
5,856 $420,000
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $909,523 - $1.08 Million
12,613
12,613 $1.02 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sun Life Financial Inc Portfolio

Follow Sun Life Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sun Life Financial Inc with notifications on news.